Total Payments
$83,311
2024 Payments
$11,828
Companies
9
Transactions
83
Medicare Patients
606
Medicare Billing
$105,397
Payment Breakdown by Category
Other$49,800 (59.8%)
Consulting$24,821 (29.8%)
Travel$5,881 (7.1%)
Food & Beverage$2,798 (3.4%)
Education$11.92 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $44,425 | 11 | 53.3% |
| Consulting Fee | $24,821 | 11 | 29.8% |
| Travel and Lodging | $5,881 | 18 | 7.1% |
| Honoraria | $5,025 | 4 | 6.0% |
| Food and Beverage | $2,798 | 37 | 3.4% |
| Grant | $350.00 | 1 | 0.4% |
| Education | $11.92 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Daiichi Sankyo Inc. | $27,736 | 23 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $23,017 | 20 | $0 (2024) |
| PFIZER INC. | $19,665 | 16 | $0 (2022) |
| Gilead Sciences, Inc. | $7,239 | 8 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $3,731 | 8 | $0 (2019) |
| Athenex Pharmaceutical Division, LLC | $1,625 | 3 | $0 (2020) |
| Merck Sharp & Dohme LLC | $141.55 | 2 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $138.98 | 2 | $0 (2019) |
| Midatech Pharma US Inc | $17.05 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $11,828 | 13 | Gilead Sciences, Inc. ($7,227) |
| 2023 | $8,843 | 9 | Daiichi Sankyo Inc. ($8,543) |
| 2022 | $17,368 | 16 | AstraZeneca Pharmaceuticals LP ($8,961) |
| 2021 | $15,760 | 7 | PFIZER INC. ($9,325) |
| 2020 | $20,489 | 19 | Daiichi Sankyo Inc. ($15,990) |
| 2019 | $8,911 | 15 | PFIZER INC. ($5,086) |
| 2017 | $112.86 | 4 | PFIZER INC. ($50.59) |
All Payment Transactions
83 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $132.83 | General |
| Category: Oncology | ||||||
| 12/11/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $80.23 | General |
| 11/15/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $1,640.00 | General |
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Consulting Fee | Cash or cash equivalent | $1,370.00 | General |
| Category: Oncology | ||||||
| 07/26/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Consulting Fee | Cash or cash equivalent | $1,027.50 | General |
| Category: Oncology | ||||||
| 05/03/2024 | AstraZeneca Pharmaceuticals LP | — | Grant | Cash or cash equivalent | $350.00 | General |
| 04/16/2024 | Gilead Sciences, Inc. | Trodelvy (Drug) | Consulting Fee | Cash or cash equivalent | $6,020.00 | General |
| Category: ONC | ||||||
| 04/16/2024 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $89.37 | General |
| Category: ONC | ||||||
| 04/11/2024 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $96.66 | General |
| Category: ONC | ||||||
| 04/11/2024 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $25.55 | General |
| Category: ONC | ||||||
| 04/10/2024 | Gilead Sciences, Inc. | Trodelvy (Drug) | Travel and Lodging | In-kind items and services | $548.19 | General |
| Category: ONC | ||||||
| 04/10/2024 | Gilead Sciences, Inc. | Trodelvy (Drug) | Travel and Lodging | In-kind items and services | $226.86 | General |
| Category: ONC | ||||||
| 04/10/2024 | Gilead Sciences, Inc. | Trodelvy (Drug) | Travel and Lodging | In-kind items and services | $220.54 | General |
| Category: ONC | ||||||
| 12/06/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $54.51 | General |
| 12/05/2023 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $61.32 | General |
| 06/02/2023 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $122.93 | General |
| Category: Oncology | ||||||
| 05/04/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $61.60 | General |
| 02/06/2023 | Daiichi Sankyo Inc. | Enhertu (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,500.00 | General |
| Category: ONCOLOGY | ||||||
| 02/03/2023 | Daiichi Sankyo Inc. | Enhertu (Drug) | Travel and Lodging | In-kind items and services | $103.62 | General |
| Category: ONCOLOGY | ||||||
| 01/26/2023 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $111.30 | General |
| Category: ONCOLOGY | ||||||
| 01/24/2023 | Daiichi Sankyo Inc. | Enhertu (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,750.00 | General |
| Category: ONCOLOGY | ||||||
| 01/19/2023 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $77.88 | General |
| Category: ONCOLOGY | ||||||
| 12/16/2022 | Daiichi Sankyo Inc. | ENHERTU (Drug) | Consulting Fee | Cash or cash equivalent | $1,370.00 | General |
| Category: ONCOLOGY | ||||||
| 12/16/2022 | Daiichi Sankyo Inc. | ENHERTU (Drug) | Consulting Fee | Cash or cash equivalent | $685.00 | General |
| Category: ONCOLOGY | ||||||
| 11/03/2022 | Daiichi Sankyo Inc. | ENHERTU (Drug) | Food and Beverage | In-kind items and services | $121.13 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 129 | 239 | $59,051 | $26,279 |
| 2022 | 3 | 128 | 226 | $53,276 | $24,528 |
| 2021 | 4 | 163 | 251 | $55,927 | $28,022 |
| 2020 | 5 | 186 | 286 | $66,317 | $26,568 |
Total Patients
606
Total Services
1,002
Medicare Billing
$105,397
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 80 | 188 | $45,047 | $20,564 | 45.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 30 | 30 | $10,264 | $4,232 | 41.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 19 | 21 | $3,740 | $1,483 | 39.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 77 | 175 | $39,749 | $18,728 | 47.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 31 | 31 | $10,153 | $4,456 | 43.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 20 | 20 | $3,374 | $1,343 | 39.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 72 | 151 | $32,565 | $17,733 | 54.5% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 33 | 33 | $10,725 | $4,856 | 45.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 39 | 48 | $7,374 | $3,725 | 50.5% |
| 99358 | Prolonged patient service without direct patient contact first hour | Facility | 2021 | 19 | 19 | $5,263 | $1,707 | 32.4% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 74 | 172 | $36,980 | $15,608 | 42.2% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 46 | 46 | $14,950 | $6,428 | 43.0% |
| 99358 | Prolonged patient service without direct patient contact first hour | Facility | 2020 | 36 | 37 | $10,249 | $3,401 | 33.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 19 | 20 | $3,060 | $805.74 | 26.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 11 | 11 | $1,078 | $324.78 | 30.1% |
About Dr. Ricardo Costa, MD
Dr. Ricardo Costa, MD is a Specialist healthcare provider based in Tampa, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/15/2007. The National Provider Identifier (NPI) number assigned to this provider is 1437348521.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ricardo Costa, MD has received a total of $83,311 in payments from pharmaceutical and medical device companies, with $11,828 received in 2024. These payments were reported across 83 transactions from 9 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($44,425).
As a Medicare-enrolled provider, Costa has provided services to 606 Medicare beneficiaries, totaling 1,002 services with total Medicare billing of $105,397. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Medical Oncology
- Location Tampa, FL
- Active Since 10/15/2007
- Last Updated 07/24/2025
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1437348521
Products in Payments
- Enhertu (Drug) $24,533
- IBRANCE (Drug) $19,540
- ENHERTU (Biological) $8,997
- Trodelvy (Drug) $7,227
- ENHERTU (Drug) $3,204
- LYNPARZA (Drug) $2,398
- Oral Paclitaxel (Drug) $1,625
- KISQALI (Drug) $138.98
- IMFINZI (Biological) $122.93
- Gelclair (Device) $17.05
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Tampa
Dr. Elliot Cazes, M.d, M.D
Specialist — Payments: $753,247
Specialist $753,247
Dr. George Letson, M.d, M.D
Specialist — Payments: $444,034
Specialist $444,034
Dr. Matthew Berlet, M.d, M.D
Specialist — Payments: $137,367
Specialist $137,367
Jose Ferreira, Md, MD
Specialist — Payments: $132,962
Specialist $132,962
Dr. Nirav Patel, M.d, M.D
Specialist — Payments: $104,346
Specialist $104,346
Elizabeth Tan-Chiu, M.d, M.D
Specialist — Payments: $54,301
Specialist $54,301